Genoray Statistics

Total Valuation

Genoray has a market cap or net worth of KRW 70.15 billion. The enterprise value is 80.33 billion.

Market Cap	70.15B
Enterprise Value	80.33B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Apr 2, 2025

Share Statistics

Genoray has 12.73 million shares outstanding. The number of shares has decreased by -2.75% in one year.

Current Share Class	n/a
Shares Outstanding	12.73M
Shares Change (YoY)	-2.75%
Shares Change (QoQ)	-2.15%
Owned by Insiders (%)	30.58%
Owned by Institutions (%)	1.17%
Float	8.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.69
PB Ratio	0.82
P/TBV Ratio	0.83
P/FCF Ratio	7.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.84, with an EV/FCF ratio of 8.81.

EV / Earnings	-44.69
EV / Sales	0.75
EV / EBITDA	5.84
EV / EBIT	12.34
EV / FCF	8.81

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.34.

Current Ratio	2.42
Quick Ratio	0.89
Debt / Equity	0.34
Debt / EBITDA	2.12
Debt / FCF	3.20
Interest Coverage	6.76

Financial Efficiency

Return on equity (ROE) is -2.81% and return on invested capital (ROIC) is 3.54%.

Return on Equity (ROE)	-2.81%
Return on Assets (ROA)	3.28%
Return on Invested Capital (ROIC)	3.54%
Return on Capital Employed (ROCE)	7.00%
Revenue Per Employee	309.20M
Profits Per Employee	-5.20M
Employee Count	346
Asset Turnover	0.86
Inventory Turnover	1.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.15% in the last 52 weeks. The beta is 0.56, so Genoray's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-19.15%
50-Day Moving Average	5,659.60
200-Day Moving Average	5,931.30
Relative Strength Index (RSI)	39.03
Average Volume (20 Days)	9,552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genoray had revenue of KRW 106.98 billion and -1.80 billion in losses. Loss per share was -135.00.

Revenue	106.98B
Gross Profit	39.30B
Operating Income	6.51B
Pretax Income	-5.99B
Net Income	-1.80B
EBITDA	13.76B
EBIT	6.51B
Loss Per Share	-135.00

Full Income Statement

Balance Sheet

The company has 18.40 billion in cash and 29.18 billion in debt, giving a net cash position of -10.79 billion or -847.28 per share.

Cash & Cash Equivalents	18.40B
Total Debt	29.18B
Net Cash	-10.79B
Net Cash Per Share	-847.28
Equity (Book Value)	85.28B
Book Value Per Share	6,712.35
Working Capital	43.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.27 billion and capital expenditures -4.15 billion, giving a free cash flow of 9.12 billion.

Operating Cash Flow	13.27B
Capital Expenditures	-4.15B
Free Cash Flow	9.12B
FCF Per Share	716.28

Full Cash Flow Statement

Margins

Gross margin is 36.74%, with operating and profit margins of 6.08% and -1.68%.

Gross Margin	36.74%
Operating Margin	6.08%
Pretax Margin	-5.60%
Profit Margin	-1.68%
EBITDA Margin	12.86%
EBIT Margin	6.08%
FCF Margin	8.52%

Dividends & Yields

This stock pays an annual dividend of 160.00, which amounts to a dividend yield of 2.97%.

Dividend Per Share	160.00
Dividend Yield	2.97%
Dividend Growth (YoY)	12.50%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.75%
Shareholder Yield	5.72%
Earnings Yield	-2.56%
FCF Yield	13.00%

Dividend Details

Stock Splits

The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.

Last Split Date	Feb 21, 2020
Split Type	Forward
Split Ratio	3

Scores

Genoray has an Altman Z-Score of 3.63.

Altman Z-Score	3.63
Piotroski F-Score	n/a